Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News VIVA 2023

New Carotid Stent Systems Associated With Low Stroke Risk

L.A. McKeown

November 09, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Clasp IID Updates and Complex Anatomy Registry

Presenter: Robert Smith

October 26, 2023

Presentation TCT 2023

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Presenter: Josep Rodés-Cabau

October 26, 2023

Presentation TCT 2023

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

Presenter: Suzanne Arnold

October 26, 2023

Presentation TCT 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 26, 2023

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

Presentation TCT 2023

How I Have Started to Use DCB’s: A Look into the Future

Presenter: Antonio Colombo

October 25, 2023

Presentation TCT 2023

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Advertisement

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

New Carotid Stent Systems Associated With Low Stroke Risk

What’s Going to Be Hot at AHA 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Clasp IID Updates and Complex Anatomy Registry

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

How I Have Started to Use DCB’s: A Look into the Future

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Exemplary Cases From the LIFE-BTK Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content